Norbert Bannert
Overview
Explore the profile of Norbert Bannert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
2475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hohn O, Meixenberger K, Volkwein A, Korner K, Icli S, Koppe U, et al.
BMC Infect Dis
. 2024 Nov;
24(1):1228.
PMID: 39487409
Objectives: People living with HIV (PLWH) are a risk group for severe symptoms and higher mortality during COVID-19. We analyzed the dynamic rise of SARS-CoV-2 seroprevalence induced by coinfections and...
2.
Bernauer H, Schlor A, Maier J, Hanack K, Bannert N, Ivanusic D
MicroPubl Biol
. 2024 May;
2024.
PMID: 38698909
Monitoring specific antibodies derived from whole-cell immunization through cell-based ELISA methods poses challenges due to humoral responses against various cell proteins. In this report, we outline a technique involving pre-adsorption...
3.
Ivanusic D, Maier J, Icli S, Falcone V, Bernauer H, Bannert N
iScience
. 2024 Feb;
27(3):109123.
PMID: 38380248
Conventional neutralizing enzyme-linked immunosorbent assay (ELISA) systems for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mimic the protein-protein interaction between angiotensin-converting enzyme 2 (ACE2) and the receptor-binding domain (RBD). However,...
4.
Bernauer H, Maier J, Bannert N, Ivanusic D
Biol Methods Protoc
. 2024 Feb;
9(1):bpae001.
PMID: 38332985
Enzyme-linked immunosorbent assay (ELISA) systems use plates coated with peptides or expressed and purified proteins to monitor immunoglobulins derived from patient serum. However, there is currently no easy, flexible, and...
5.
Koppke J, Keller L, Stuck M, Arnow N, Bannert N, Doellinger J, et al.
Nat Commun
. 2024 Jan;
15(1):299.
PMID: 38182622
Viruses that carry a positive-sense, single-stranded (+ssRNA) RNA translate their genomes soon after entering the host cell to produce viral proteins, with the exception of retroviruses. A distinguishing feature of...
6.
Toudic C, Maurer M, St-Pierre G, Xiao Y, Bannert N, Lafond J, et al.
Viruses
. 2023 Dec;
15(12).
PMID: 38140682
Syncytin-1 and -2 are glycoproteins encoded by human endogenous retrovirus (hERV) that, through their fusogenic properties, are needed for the formation of the placental syncytiotrophoblast. Previous studies suggested that these...
7.
Bernauer H, Schlor A, Maier J, Bannert N, Hanack K, Ivanusic D
Biol Methods Protoc
. 2023 Dec;
8(1):bpad030.
PMID: 38090673
Successful induction of antibodies in model organisms like mice depends strongly on antigen design and delivery. New antigen designs for immunization are helpful for developing future therapeutic monoclonal antibodies (mAbs)....
8.
Fiebig U, Altmann B, Hauser A, Koppe U, Hanke K, Gunsenheimer-Bartmeyer B, et al.
BMC Infect Dis
. 2023 Oct;
23(1):673.
PMID: 37817087
Background: The transmission of resistant HIV variants jeopardizes the effective use of antiretrovirals for therapy and prophylaxis. Molecular surveillance of new HIV diagnoses with a focus on prevalence and type...
9.
Fiebig U, Altmann B, Hauser A, Koppe U, Hanke K, Gunsenheimer-Bartmeyer B, et al.
Dtsch Arztebl Int
. 2023 Sep;
120(27-28):479-480.
PMID: 37661317
No abstract available.
10.
Schmidt D, Kollan C, Schewe K, Hanhoff N, Rusenberg R, Friebe M, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
. 2023 Jul;
66(9):1008-1018.
PMID: 37436444
Background: We investigated the impact of HIV pre-exposure prophylaxis (PrEP) as a new service of the statutory health insurance (SHI) on the incidence of HIV and other sexually transmitted infections...